Breaking News, Promotions & Moves

Vaximm Taps Sébastien Wieckowski as New Chief Scientific Officer

Wieckowski has already played a central role in the development of Vaximm’s lead candidate in oncology.

Author Image

By: Patrick Lavery

Content Marketing Editor

Vaximm AG has named Sébastien Wieckowski, PhD, Chief Scientific Officer. The company, a subsidiary of OSR Holdings, specializes in oral T-cell immunotherapies for cancer. According to Vaximm, Wieckowski has multidisciplinary experience including the areas of immunology and advanced data science. Chief Scientific Officer’s Role Vaximm is currently advancing its lead candidate, VXM01, through further stages of clinical development. VXM01 targets vascular endothelial growth factor receptor...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters